Research Topics
| Andrew J StephensonSummaryAffiliation: Cleveland Clinic Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomyAndrew J Stephenson
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Eur Urol 61:443-51. 2012....- Current treatment options for clinical stage I seminomaAndrew J Stephenson
Center for Urology Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
World J Urol 27:427-32. 2009..Adjuvant dog-leg radiotherapy is the preferred approach for non-compliant patients or those unwilling to go on surveillance... 
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
J Clin Oncol 25:2035-41. 2007..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...- Analysis of T1c prostate cancers treated at very low prostate-specific antigen levelsAndrew J Stephenson
Section of Urologic Oncology, Glickman Urological and Kidney Institute, Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195 0001, USA corrected
Eur Urol 55:610-6. 2009..5 ng/ml) given the 17% prostate cancer (pCA) detection rate at PSA of 1.1-2.0. The outcome of patients treated at PSA < or = 2.5 is poorly defined, and advantages associated with such an early diagnosis are uncertain... - Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysisCarvell T Nguyen
Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Desk Q10, Cleveland OH, 44195 0001, USA
J Clin Oncol 28:119-25. 2010..Surveillance was the preferred intervention for all except those patients at high risk for relapse... - Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomyAndrew J Stephenson
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
J Urol 182:1357-63. 2009..In a multicenter study we analyzed the predictive usefulness of several subclassifications of positive surgical margins... - Surgical management of low-stage nonseminomatous germ cell testicular cancerAndrew J Stephenson
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
BJU Int 104:1362-8. 2009..The therapeutic efficacy of laparoscopic RPLND is not proven and currently should be considered a staging procedure only. Adjuvant chemotherapy after RPLND is typically restricted to patients with pathological stage N2-3 disease... - Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomesAndrew J Stephenson
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195 0001, USA
BJU Int 102:1296-301. 2008..Randomized trials are necessary to determine if the results achieved with LRC are equivalent to those of ORC... - Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Andrew J Stephenson
Department of Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 78:S444-55. 2011..To advise urologists and other clinicians on the appropriate management of low-stage (clinical Stage [CS] I, IS, IIA, and IIB) nonseminomatous germ cell tumors of the testis... - Chemoprevention of prostate cancerAndrew J Stephenson
Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk Q10 1, Cleveland, OH 44195 0001, USA
Urol Clin North Am 37:11-21, Table of Contents. 2010..5alpha-reductase inhibitors represent an effective primary prevention strategy, and these agents should be used more liberally for the prevention of prostate cancer, particularly in high-risk patients... - Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Cancer 116:2967-73. 2010..Although multimodal treatment paradigms for UTUC are under-developed, this has important implications on patients' ability to receive cisplatin-based combination chemotherapy (CBCC)... - Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary seriesChristopher J Weight
Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195 0001, USA
Cancer 115:792-9. 2009..The outcome of NC and open radical cystectomy (RC) was evaluated in a contemporary cohort of patients in a tertiary referral setting... - Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Natl Cancer Inst 98:715-7. 2006..Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy... - Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladderIslam A Ghoneim
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
Urology 77:867-70. 2011..Radical cystectomy is considered the standard approach for treatment of patients with localized disease; however, the role of perioperative systemic therapy has been poorly defined... 
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasionAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Urol 174:557-60; discussion 560. 2005..After primary RPLND and selective adjuvant chemotherapy late recurrence is distinctly uncommon and long-term cancer control is anticipated in essentially all patients...- Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Clin Oncol 23:7005-12. 2005..Unique to predictive models, the nomogram predictions can be adjusted for the disease-free interval that a patient has achieved after RP... - Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 25:5597-602. 2007..3). CONCLUSION Patient selection factors have significantly improved the outcome of patients with CS IIA and IIB NSGCT without substantially increasing the proportion of patients exposed to chemotherapy... - Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative managementArmine K Smith
Glickman Urological and Kidney Institute, Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
Urology 78:82-6. 2011..However, concerns about potential understaging, inaccurate grading, incomplete resection, lack of effective tertiary chemoprevention, and need for ureteroscopic surveillance limits it appeal... - Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapyFernando J Bianco
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 62:448-53. 2005..Long-term control of locally recurrent prostate cancer after definitive RT is possible when salvage RP is performed early in the course of recurrent disease... - Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definitionAndrew J Stephenson
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:3973-8. 2006..Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression... - Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping studyRanko Miocinovic
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195 0001, USA
J Urol 186:1269-73. 2011..We evaluated the incidence of positive lymph nodes in the presacral and retroperitoneal regions in patients who underwent radical cystectomy and extended pelvic lymph node dissection for urothelial bladder cancer... - The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survivalCarvell T Nguyen
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
J Urol 181:75-80. 2009..Various schemes based on clincopathological criteria have been proposed to stratify cases by presumed recurrence risk. We determined whether survival outcomes are dependent on the specific definition... - The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomyMichael C Lee
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Eur Urol 58:90-5. 2010..Few reports attempt to validate the role of Epstein criteria in selecting patients for an active surveillance protocol... - Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen eraAndrew J Stephenson
Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
J Clin Oncol 27:4300-5. 2009..Models that predict the risk of PCSM are needed for patient counseling and clinical trial design... - Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
BJU Int 94:1210-2. 2004 - Nomograms for prostate cancerAndrew J Stephenson
Section of Urologic Oncology, Glickman Urological Institute, Lerner College of Medicine, Cleveland, OH, USA
BJU Int 98:39-46. 2006 - Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancerVairavan S Subramanian
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Urol Oncol 28:504-9. 2010..We sought to compare the complication profile of primary (P-) and post-chemotherapy (PC-) RPLND using a standardized complication grading scale... - Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteriaRanko Miocinovic
Glickman Urololgical and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Urology 77:980-4. 2011..To analyze the acceptance rate and durability of surveillance among contemporary men with low-risk prostate cancer managed at a large, US academic institution... - Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapyMatthew N Simmons
Glickman Urological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue A100, Cleveland, OH 44195, USA
Eur Urol 51:1175-84. 2007..While a rising PSA level universally antedates metastatic progression and prostate cancer-specific mortality (PCSM), it is not a surrogate for these endpoints. Thus, the management of patients with BCR is controversial... - Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancerAndrew J Stephenson
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 75:382-6. 2010..The aggregate LN metastasis diameter (ALNMD) may better reflect the burden of metastatic disease and improve the ability to predict recurrence-free (RFS) and overall survival (OS)... - Salvage radiotherapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
JAMA 291:1325-32. 2004..Selected patients with high-grade disease and/or a rapid PSADT who were previously thought to be destined to develop progressive metastatic disease may achieve a durable response to salvage radiotherapy... - Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcomeAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 23:2781-8. 2005..For patients with normal STM and CS I to IIA disease, the low rate of systemic progression and 22% incidence of retroperitoneal teratoma supports RPLND as the preferred primary intervention... - Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomyBrian R Lane
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Urology 72:1240-5. 2008..The results from 3 retrospective studies have suggested that low pretreatment testosterone is an independent predictor of adverse pathologic features in patients with localized prostate cancer... - Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatmentRanko Miocinovic
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 77:946-50. 2011..To examine the ability of surgery as initial management in avoiding androgen deprivation therapy (ADT) in patients with high-risk localized prostate cancer... - Management of clinical stage I nonseminomatous germ cell testicular cancerToni K Choueiri
Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
Urol Clin North Am 34:137-48; abstract viii. 2007..For patients at high risk for relapse and who are not candidates for surveillance, we believe the evidence supports RPLND over primary chemotherapy... - Prostate cancer volume at biopsy predicts clinically significant upgradingFei Dong
Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
J Urol 179:896-900; discussion 900. 2008..We identified clinical and pathological parameters that predict pathological upgrading in this population... - Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladderAnil A Thomas
Glickman Urological and Kidney Institute, The Cleveland Clinic, Cleveland, OH 44195, USA
Hum Pathol 40:108-16. 2009.... - A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancerEdouard J Trabulsi
Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Urology 72:1298-302; discussion 1302-4. 2008..We studied a group of patients undergoing ART by comparing them with a matched control group undergoing SRT after biochemical failure... - Surgical resection of renal cell carcinoma after targeted therapyAnil A Thomas
Glickman Urological and Kidney Institute, Cleveland, Ohio 44195, USA
J Urol 182:881-6. 2009..The integration of targeted therapy and surgery requires careful consideration due to the potential for increased perioperative morbidity... - Bacillus Calmette-Guérin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladderAmit R Patel
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Eur Urol 58:934-7. 2010..The patient was treated with isoniazid, rifampin, ethambutol, and pyrazinamide... - Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumorsCarvell T Nguyen
Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Q10, Cleveland, OH 44195, USA
Hematol Oncol Clin North Am 25:593-604, ix. 2011..This article reviews the indications, technique, and outcomes of PC-RPLND in the management of advanced GCT... - American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumorsTimothy D Gilligan
Taussig Cancer Institute and the Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
J Clin Oncol 28:3388-404. 2010..To provide recommendations on appropriate uses for serum markers of germ cell tumors (GCTs)... - Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practiceFei Dong
School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
J Urol 180:150-4; discussion 154. 2008..In patients referred for biopsy following community screening we validated the Kattan and Steyerberg nomograms for predicting indolent disease in a contemporary urological practice... - Management of patients with low-stage nonseminomatous germ cell testicular cancerAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Treat Options Oncol 6:367-77. 2005.... - Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 23:8198-203. 2005..Salvage RP may favorably alter the natural history of biochemical recurrence after radiation therapy, but it must be instituted early in the course of recurrent disease to be effective... - Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapyTimothy A Masterson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Urology 66:623-6. 2005..Peripheral nerve grafts did not appear to influence the recovery of erections in this patient population... - Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancerAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Urol 176:1996-9; discussion 1999. 2006.... - Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Urol 172:2239-43. 2004..The acceptable morbidity profile of salvage RP following EBRT and transperineal IRT should persuade more physicians to consider patients for this potentially curative procedure... - Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 104:290-8. 2005.... - Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombiVairavan S Subramanian
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 74:154-9. 2009..Preoperative embolization has been used as an adjunctive procedure to facilitate surgical resection of complex renal tumors... - The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatmentJay P Ciezki
Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 75:467-71. 2010..To assess the relationship between prostate-specific antigen (PSA) testing frequency and biochemical failure (bF) and clinical failure (cF)... - The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Nat Clin Pract Urol 1:90-6. 2004..To be successful, salvage EBRT should be administered at the earliest evidence of recurrent disease, once a rising PSA trend as been confirmed... - Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?Amit R Patel
Center for Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 0001, USA
Nat Rev Urol 8:385-92. 2011.... - The role of retroperitoneal lymph node dissection in the management of testicular cancerAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Urol Oncol 22:225-33; discussion 234-5. 2004..This article reviews the role of RPLND in the management of patients with NSGCT at all stages and its role in advanced seminoma... - Are nomograms needed in the management of bladder cancer?Carvell T Nguyen
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Urol Oncol 28:102-7. 2010..Although their use has become more widespread, bladder cancer nomograms remain a relatively nascent field of study, and further development of novel nomograms that can account for all clinical stages of bladder cancer is needed... - Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume center experienceMaria C Mir
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Ann Surg Oncol 20:1456-61. 2013..Previous studies reported increased recurrence rates associated with laparoscopic adrenalectomy (LA). We evaluated a single-center experience of LA versus open adrenalectomy (OA) for the management of ACC... - Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpartJennifer Ko
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Prostate 73:897-903. 2013..Consensus on prostate cancer (PCA) treatment in older men is currently lacking. We evaluated clinicopathological and oncological outcomes in patients >70-year-old treated with radical prostatectomy (RP)... - When serial prostate biopsy is recommended: most cancers detected are clinically insignificantOsama M Zaytoun
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
BJU Int 110:987-92. 2012..Moreover, it addressed the impact of detecting premalignant lesions on further detection of cancer in serial biopsy... - Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinomaKatherine E Watts
Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio 44195, USA
Urology 80:361-6. 2012..To investigate the clinicopathologic and immunohistochemical features associated with invasive low-grade papillary urothelial carcinoma (LGPUC), an uncommon entity not previously described in published studies... - Screening for urologic malignancies in primary care: pros, cons, and recommendationsAndrew J Stephenson
Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Cleve Clin J Med 74:S6-14. 2007.... - Clinicians Versus Nomogram: Predicting Future Technetium-99m Bone Scan Positivity in Patients With Rising Prostate-specific Antigen After Radical Prostatectomy for Prostate CancerMichael W Kattan
Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH Electronic address
Urology 81:956-61. 2013..To compare the ability of clinicians vs a nomogram at predicting future bone scan positivity in patients with prostate cancer... - Multidisciplinary management of patients with localized bladder cancerKiranpreet K Khurana
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Surg Oncol Clin N Am 22:357-73. 2013..Bladder-preservation protocols involving a visibly complete transurethral resection followed by chemoradiation may be a feasible option for select patients... - Management of poor-prognosis testicular germ cell tumorsKiranpreet Khurana
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH Department of Solid Tumor Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA
Indian J Urol 26:108-14. 2010..A complete surgical resection of all residual sites of disease after chemotherapy is critical for the prevention of relapse and the long-term survival of patients with advanced germ cell tumors... - Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumorAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 171:1474-7. 2004..In a cohort of patients who underwent exploratory laparotomy for unsuspected metastatic GCT we determined the impact of this surgery on morbidity, therapeutic delay and cancer therapy... - Complications of radical and partial nephrectomy in a large contemporary cohortAndrew J Stephenson
Department of Urology, Sidney Kimmel Cancer Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Urol 171:130-4. 2004..Compared to RN, PN is associated with higher rates of procedure related complications, the majority of which are minor. Overall, however, PN is not associated with more complications than RN... - Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinationsPhillip L Ross
Division of Urology, McGill University, Montreal, Quebec, Canada
Urology 64:323-8. 2004..CONCLUSIONS: In untreated patients with localized prostate cancer, the PSADT varies considerably depending on the interval evaluated... - Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)Andrew J Stephenson
Urology 72:719-20. 2008 - Salvage therapy for locally recurrent prostate cancer after external beam radiotherapyAndrew J Stephenson
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Treat Options Oncol 5:357-65. 2004..A long-term cure is possible for patients with locally recurrent prostate cancer after radiation therapy. Local salvage therapy must be instituted early to be successful in the course of progressive disease... - Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancerAndrew J Stephenson
Department of Surgery (Urology, McGill University, Montreal, Ontario, Canada
Urology 59:652-6. 2002..CONCLUSIONS: A PSADT of less than 120 months correlates with disease progression. However, its clinical utility remains limited to identify patients at risk of disease progression reliably... - Systems pathology and predicting outcome after radical prostatectomyEric A Klein
J Clin Oncol 26:3916-7. 2008 - Gene expression profiling predicts clinical outcome of prostate cancerGennadi V Glinsky
Sidney Kimmel Cancer Center, San Diego, California 92121, USA
J Clin Invest 113:913-23. 2004.... - Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomyAndrew J Stephenson
Division of Urology, McGill University, , , Canada
J Urol 172:58-62. 2004..The higher risk of abdominal relapse in patients with pT3A-B indicates that they should receive surveillance abdominal imaging. We recommend abdominal computerized tomography 6, 12, 24 and 36 months postoperatively...